Computer-Aided Detection Market Size, Share & Trends Analysis Report By Technology (Deep Learning-Based, Machine Learning-Based, Traditional CAD Systems,, Hybrid Models, Others), By Application (Tuberculosis, Breast cancer, Lung cancer, Colon/rectal cancer, Prostate cancer, Liver cancer, Bone cancer, Others (Neurological/musculoskeletal/cardiovascular Indications)), By Indication (X-ray imaging, Computed tomography, Ultrasound imaging, Magnetic resonance imaging, Nuclear medicine imaging, Others) and By Region (North America, Europe, APAC, Middle East and Africa, LATAM) Forecasts, 2026-2034

Computer-Aided Detection Market Size

The global computer-aided detection market size was valued at USD 980.99 million in 2025 and is projected to grow from USD 1031.71 million in 2026 to USD 1544.16 million by 2034, registering a CAGR of 5.17% during the forecast period from 2026 to 2034. North America dominated the computer-aided detection market with a market share of 43.68% in 2025.

Technology Insights

The deep learning-based segment dominated the computer-aided detection market share in 2025 with a share of 45.23%. With the extensive use of complex image pattern recognition across radiology and oncology workflows, CAD systems are being deployed in healthcare facilities. Deep learning models in these systems enable automated lesion detection, classification, and prioritization. This supports high-throughput diagnostic environments even in large imaging datasets.

The machine learning-based segment is projected to record a growth of 6.13% during the forecast period. Machine learning models fit well even in rule-based legacy systems, which can be deployed for structural imaging tasks. In cases where radiologists prefer statistical learning, these systems offer data building in legacy systems. These factors are expected to boost the growth of the machine learning-based segment during the forecast period.

Request Customizationto receive a tailored report.

Application Insights

The breast cancer segment held a dominant share of 60.23% in 2025, supported by the large-scale adoption of CAD software in mammography screening programs and diagnostic imaging centers. High screening volumes and standardized imaging protocols continue to drive sustained use of CAD systems in breast cancer detection workflows.

The lung cancer segment is anticipated to grow at a rate of 6.18%, driven by increasing deployment of CAD tools in chest CT screening programs and rising adoption of automated nodule detection systems in hospital radiology departments. Such factors are expected to propel the computer-aided detection market growth throughout the forecast period.

Indication Insights

The X-ray imaging segment dominated the market with a share of 35.23% in 2025, supported by widespread use of CAD solutions in chest X-ray screening, trauma assessment, and routine diagnostic imaging. High accessibility of X-ray systems across primary and secondary care facilities continues to support extensive CAD utilization.

The magnetic resonance imaging segment is expected to register a growth of 6.92%, driven by expanding use of CAD software in soft tissue visualization, oncology imaging, and neurological assessments, where advanced image interpretation supports complex diagnostic workflows.

Speak to an Analystto discuss market opportunities.

Regional Analysis

The computer-aided detection market in North America had a share of 43.68% in 2025. The market growth is driven by early adoption of AI-enabled medical imaging software and widespread availability of advanced diagnostic infrastructure across hospitals and imaging centers. The region benefits from a mature regulatory framework that supports clinical deployment of CAD software through structured FDA clearance pathways and strong integration with PACS and radiology information systems.

The US accounted for the largest regional share due to sustained investment in AI-based radiology tools, federal support for digital health adoption, and large-scale screening programs for cancer and cardiovascular disease. In January 2026, Cleerly disclosed on its corporate website that Aetna expanded insurance coverage for its AI-based coronary plaque analysis software, supporting broader clinical utilization of CAD-driven cardiovascular imaging in the US.

Unlock Regional Insightsto access country-level data, & regional trends.

Asia Pacific

Asia Pacific is emerging as a fast-expanding region with a CAGR of 7.17% during the forecast period. The region is experiencing a surge in the number of cardiovascular cases and cancer, which leads to higher demand for early detection via CAD imaging for improved patient outcomes. Thus, a larger patient pool drives demand for CAD-assisted imaging in screening programs across hospitals. The region also has rising healthcare investments that support the deployment of AI-powered diagnostic tools. Increasing investments in CT, MRI, digital X-ray, and mammography systems also include CAD. Vendors are also collaborating with hospitals and imaging chains, as seen in the case of Aidoc’s partnerships with major hospital groups in Japan, Singapore, and Australia. AI-based chest and head CT CAD solutions are also being deployed by Qure.ai across India and Southeast Asia for screening lung diseases, strokes, and tuberculosis.

China is expected to lead the Asia Pacific computer-aided detection market during the forecast period. The market is driven by modernization programs led by the government and favorable digital health policies for improved healthcare performance. This favorable environment accelerates the deployment of AI-based imaging software, thus driving the implementation of CAD. Public healthcare institutions are also relying on CAD solutions. For instance, Tencent Miying CAD solutions are used in public hospitals for early detection of chest and oncology issues. These are also aligned with the national healthcare digitalization goals.

Europe

Europe is expected to have a strong adoption of CAD solutions across healthcare facilities, which aligns with digital imaging interoperability initiatives. The integration of AI tools in healthcare systems also aligns with regional policies of upgrading the existing systems. Unified health data exchange frameworks across the EU aim at reasonable, secure cross-border access to imaging data. This enables wider deployment of CAD tools in radiology and cardiology departments. Aidoc has deployed its AI-based CAD solutions in the region for emergency detection and improved oncology frameworks.

Germany dominates the European CAD landscape due to nationwide digital health initiatives and high installation density of advanced CT and MRI systems, which support routine use of detection algorithms in hospital diagnostics. For instance, CAD platforms integrated into radiology workflows at German university hospitals using solutions from Siemens Healthineers are actively supporting automated detection and quantification in CT and MRI imaging.

Latin America

Latin America demonstrates steady growth in the computer-aided detection market, supported by government-led digital health programs focused on strengthening diagnostic infrastructure. For example, national eHealth and digital hospital initiatives under programs such as the PAHO Digital Health Initiative promote standardized imaging data exchange, electronic health records, and AI-enabled diagnostics across public healthcare systems, creating a supportive environment for CAD deployment.

Brazil supports CAD adoption through large-scale public healthcare digitization programs. Key initiatives such as Conecte SUS and the National Telehealth Brazil Networks Program focus on integrating electronic medical records, imaging systems, and decision-support technologies, enabling public hospitals to incorporate computer-aided detection into routine diagnostic workflows.

Middle East and Africa

The Middle East and Africa computer-aided detection market is expected to have steady growth during the forecast period. The region relies on digital health transformation programs such as Vision 2030 and Digital Health Leadership that are upgrading the existing healthcare infrastructure. Increased investments in advanced diagnostic technologies focus on upgrading diagnostic imaging equipment, integrating AI into existing health facilities, expanding telehealth, and building digital health capacity. These factors lead to extensive focus on using platforms and systems that guarantee secure data exchange and patient-focused care, supporting CAD deployment for accessible imaging data.

South Africa holds a leading position in the Middle East & Africa region, owing to its focus on digitizing legacy medical records on a large scale. The region is also undertaking modernization efforts for existing radiology departments, which drives the higher adoption of CAD solutions across public hospitals. The National Department of Health of South Africa, under the national digital health framework, has introduced AI-based CAD tools in public healthcare facilities. This initiative aims at automating chest X-rays and CT scans to support screening programs for chronic issues such as tuberculosis and oncology.

Competitive Landscape

The computer-aided detection market is moderately fragmented with a mix of established medical imaging companies, specialized AI diagnostic software providers, regional developers, and emerging health tech companies. Factors such as diagnostic accuracy, deployment flexibility, clinical workflow integration, diversity of training datasets, regulatory approvals, and the breadth of detectable conditions govern the competitive landscape in this market. Emerging trends in the market include machine learning integration, a shift toward cloud-based solutions, multi-condition detection, and biomarker extraction.

List of Key and Emerging Players in Computer-Aided Detection Market